Compugen (NASDAQ: CGEN) Navigates Q1 2026 Financials Amidst Clinical Progress
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameCompugen Ltd.
-
Registration countryIsrael
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









